Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 September 2014: Clinical Research  

Total Thyroidectomy is Associated with Increased Prevalence of Permanent Hypoparathyroidism

Ireneusz Nawrot ADEFG , Aneta Pragacz ABCDEF , Krzysztof Pragacz BCF , Wiesław Grzesiuk CF , Marcin Barczyński CDE

DOI: 10.12659/MSM.890988

Med Sci Monit 2014; 20:1675-1681

0 Comments

Abstract

BACKGROUND: Thyroid disorders are very common in adults. Despite advances in conservative management, surgery remains a treatment modality of choice in many cases. The mortality and morbidity of thyroidectomy are low, but long-term postoperative hypoparathyroidism (HPT) remains a prominent complication of the procedure. The aim of this study was to assess the incidence of permanent HPT and identify the risk factors for this complication in a cohort of post-thyroidectomy patients followed at a District Endocrine Clinic.

MATERIAL AND METHODS: This was a retrospective analysis of 401 patients followed up at a Regional/District Endocrine Clinic, who had undergone thyroid surgery in the years 1993–2011. The percentage of patients with permanent (>12 months) HPT was the primary endpoint of the study. The statistically analyzed data of patients with permanent HPT versus the remaining patients free from postoperative complications included their demographic data, indications for surgical treatment of their thyroid disorder, and extent of the thyroid resection. The risk factors for postoperative hypoparathyroidism were assessed using logistic regression analysis.

RESULTS: Permanent HPT following surgery on the thyroid gland occurred in 8.5% of the patients. It was more frequent following total thyroidectomy (20.2%) than near-total thyroidectomy (6.7%) or subtotal thyroidectomy (4.2%); p<0.0001. A multivariate statistical regression analysis demonstrated that primary total thyroidectomy was a significant risk factor for permanent HPT (OR 6.5; 95% CI: 2.9–14.4; p<0.0001).

CONCLUSIONS: Total thyroidectomy was associated with increased prevalence of permanent hypoparathyroidism when compared to less extensive thyroid resection modes in patients with benign thyroid diseases.

Keywords: Adolescent, Aged, 80 and over, Demography, Hypoparathyroidism - etiology, Incidence, Logistic Models, Multivariate Analysis, Prevalence, Thyroidectomy - adverse effects, young adult

Background

Thyroid disorders are very common in adults. Despite advances in conservative management, surgery remains a treatment modality of choice in many cases. The mortality and morbidity of thyroidectomy are low, but some long-term post-operative complications are still a significant health and social problem. The present study assessed the rates of permanent hypoparathyroidism (HPT) secondary to thyroid surgery, which is a prominent complication of thyroidectomy.

The aim of this study was to assess the incidence of permanent HPT and identification of the risk factors for this complication based on follow-up of post-thyroidectomy patients in the setting of an outpatient specialist clinic. The rates of permanent HPT were assessed against the demographic profiles of the patients, indications for thyroid surgery, and the extent of the resection of the thyroid gland. The risk factors for hypoparathyroidism were analyzed using the logistic regression method.

Material and Methods

STATISTICAL ANALYSIS:

The quantitative data obtained are presented as arithmetic means plus/minus standard deviation (X±SD), as well as median values. The t-test and its non-parametric equivalent, the Mann-Whitney test, were used to compare the mean quantitative variables between the 2 groups. The F-test (Snedecor) and Tukey’s multiple comparison test were used to compare the means of more than 2 groups. In cases of failure to meet the assumptions of variance analysis, the nonparametric Kruskal-Wallis test was used. The chi-square test was employed to determine the relationship between the qualitative characteristics (nonmeasurable variables) and the Fisher exact test when the expected sample size was less than 5. The assessment of potential risk factors for postoperative complications was by the logistic regression analysis. The odds ratio (OR) was determined for each risk factor. STATISTICA, SAS 9.3, and StatCrunch software was used for the calculations. The statistical significance level (P) was 0.05 or lower.

Results

Permanent HPT was identified in 8.5% (34/401) of the study patients. Factors that may affect the occurrence of permanent HPT (patient age and sex, size and location of the goiter, type of thyroid disorder, and the extent of resection) are presented in Table 2. The mean age of patients with normal parathyroid function was 50.3±12.86 years. The mean volume of the thyroid gland assessed by ultrasonography in patients with normal parathyroid function was 61.7±50.3 ml (median, 48.6 ml). There were no statistically significant differences between patients with normal parathyroid function and those with hypoparathyroidism with regard to the demographic profiles and original thyroid disorder (Table 2). However, there were statistically highly significant differences in the rates of hypoparathyroidism related to the type of thyroidectomy performed (Table 2). Statistically, permanent HPT was the most common after a repeat procedure (25%), but the redo thyroidectomy group was very small (8 patients). On the other hand, for obvious reasons, this complication did not occur after any resection of 1 thyroid lobe with the isthmus. Comparison of the permanent HPT rates with regard to the extent of thyroid resection revealed that total thyroidectomy was especially associated with postoperative permanent HPT (20.2%). The overall permanent HPT rate in all patients who had undergone any kind of primary thyroid surgery was 4.1% (12 patients). Fisher’s exact test demonstrated a statistically significant relationship between primary total thyroid resection and permanent HPT occurrence (Table 2).

The multivariate logistic regression analysis was used to assess potential risk factors for postoperative hypoparathyroidism, such as age, female sex, total thyroidectomy, autoimmune thyroid disease, and hyperthyroidism. Table 3 presents findings for a full model including all potential risk factors. The logistic regression analysis revealed that total thyroidectomy was a significant risk factor for permanent HPT (OR 6.5; 95% CI: 2.9–14.4; p<0.0001).

Discussion

Historically, cases of tetany following goiter surgery were first reported in the 1880s by the Swiss surgeon Emil Theodor Kocher, who associated its occurrence with the wound infection [1]. It was only in 1891 that the French physiologist Marcel Gley demonstrated the association between removal of the parathyroid glands and occurrence of tetany [2]. Nowadays, most authors agree that hypocalcemia as a result of either absent or very low secretion of parathormone (PTH) by the parathyroids is associated with inadequate vascular supply of the parathyroid remnants, and only rarely is it due to the accidental removal or damage to all parathyroid glands during thyroidectomy [3–5]. Thus, to avoid permanent hypoparathyroidism, it is recommended to identify as many parathyroid glands as possible and to be meticulous during surgical dissection in order to preserve them in situ with an intact vascular supply. However, in cases of inadvertent removal or devascularization of parathyroid glands, all surgeons agree that immediate parathyroid autotransplantation into the sterno-cleido-mastoid muscle should be used to prevent permanent hypoparathyroidism. Intraoperative iPTH assay can be used to guide the surgeon if parathyroid tissue autotransplantation should be done [6]. According to published studies, inadvertent removal of 1 or 2 parathyroid glands during surgery does not result in postoperative hypocalcemia [7]. Hypocalcemia following surgery may be either completely asymptomatic or present with varying features of neuromuscular irritability, such as tetany and equivalent disorders. Patients usually complain of numbness around the mouth (circumoral paresthesia), or muscle cramps and twitching, and a tingling sensation in the hands [8,9]. Acute hypocalcemia may be manifested by life-threatening cardiovascular events, including a form of ventricular tachycardia known as torsade de pointes, heart blocks, hypocalcemic cardiomyopathy, and heart failure [8,9]. Postoperative parathyroidism requires regular endocrine monitoring and care. It may be successfully treated, although appropriate therapy is sometimes difficult. The clinical features of the disorder include calcification of the basal ganglia, leading to neurological and psychiatric disorders such as extrapyramidal syndromes, Parkinsonism, depression, neuroses, and psychoses. Other characteristic signs (e.g., dry skin, brittle hair and nails, or subcapsular cataract) are trophic changes of tissues derived from ectoderm [8,9].

Treatment of acute severe hypocalcemia after thyroidectomy consists of intravenous administration of calcium carbonate, active metabolites of vitamin D, and in some cases thiazide diuretics and phosphate-binders such as aluminum phosphate and aluminum carbonate [8,9]. Serum calcium and phosphorus concentrations are measured regularly and patients must be monitored for calciuria to prevent the symptoms and effects of hypocalcemia and the complications of the treatment, which may include hypercalcemic crisis and renal stones [8]. Usually, up to 12 months after thyroidectomy, normal parathyroid function is recovered and normocalcemia and calcium supplementation may be discontinued [1,3,10]. In the opinion of some authors, recovery of parathyroid function, even when there is postoperative tetany, is possible as late as over 2 years after thyroid surgery. PTH levels normalize and treatment for hypoparathyroidism may be stopped [10,11].

According to the literature, the risk of permanent hypothyroidism is up to 17.3% following thyroid surgery for carcinoma [12]. Compared to the literature data, the overall permanent HPT rate in the present study, which excluded malignant thyroid disease, was high, at 8.5%. Our analysis focused on the effects of risk factors for the development of thyroidectomy complications described in the literature. These factors include female sex and elderly age, a large and substernal goiter, autoimmune thyroid disease and hyperthyroidism, and the extent of thyroidectomy. Although the predominant opinion is that older age (over 65 years) is not a risk factor for postoperative complications, thyroidectomy in the elderly is usually undertaken in cases of cytological diagnosis, suspicion of a malignant thyroid lesion, or the presence of a goiter producing compression symptoms [13–16]. In this study, we found no significant association between older age and permanent HPT, although Thomusch et al., in their analysis of 7266 patients who had undergone benign goiter surgery, found that age was a significant risk factor for this complication [17]. The relationship between patient sex and postoperative hypoparathyroidism is a subject of much controversy. The present study and many other published studies did not confirm any correlation between patient sex and permanent HPT [18]. However, large multicenter analyses from Greece and Germany demonstrated that the risk of permanent hypoparathyroidism was 1.5- to 2.4-fold greater in females [17,19].

Many published studies suggest that the incidence of permanent HPT as a postoperative complication is significantly affected by the original thyroid disease [7,17–21]. Many authors indicate that Graves’ disease is an independent risk factor for postoperative hypoparathyroidism [7,17,19,22]. Thus, Witte et al. found a high rate of permanent HPT (5.3%) in patients with the diagnosis of Graves’ disease [23]. In the study by Yip et al., 4% of permanent HPT cases were reported after thyroidectomy for Graves’ disease [24], which is why patients with Graves’ disease are only rarely referred for thyroid surgery. Similarly, in the present study they accounted for just 3.5% of all patients, but there were no cases of permanent HPT in this subgroup. There are some literature reports that claim thyroid surgery does not carry a high risk of complications in Graves’ disease, including patients with high titers of the anti-TSH receptor antibodies [25]. Hallgrimsson et al. found that the differences in the incidence of hypocalcemia following total thyroidectomy for Graves’ disease and for nontoxic multinodular goiter were not statistically significant [21]. In the opinion of most surgeons, Hashimoto’s disease is associated with an increased risk for postoperative complications [26]. In our study, no cases of permanent HPT were found in patients with a history of Hashimoto’s disease. This is in agreement with observations of Wormer et al., who did not find permanent HTP in any of the patients operated on for Hashimoto’s goiter [27].

In the present study we did not observe any association between the volume and position of the thyroid and the occurrence permanent HTP, which is consistent with the findings reported by some authors [22,28], but others noted a positive correlation between the size of the goiter and its retrosternal location and the occurrence of permanent HTP [29,30]. The optimal extent of thyroid surgery has been long debated by teams of endocrinologists and surgeons. The operation should be radical to achieve good disease control, but minimizing potential post-thyroidectomy complications is equally important [31]. Several types of surgery are employed in the treatment of benign thyroid disease, including total resection of 1 lobe of the thyroid with the isthmus, subtotal removal of both lobes, as well as total or near-total resection of the thyroid gland. An unquestionable advantage of a wide extent of thyroid resection is a lower rate of multinodular goiter recurrence compared to subtotal thyroidectomy [28]. Additionally, following complete excision of the thyroid gland compared to subtotal thyroidectomy, radical reoperative surgery is less frequently required when carcinoma is diagnosed at postoperative histological examination of thyroid tissue surgically removed for indications other than carcinoma [32,33]. Prompt cure of hyperthyroidism, without a further risk of goiter and hyperthyreosis relapse, is another advantage of total and near-total thyroidectomy.

Opinions concerning the frequency of complications following less or more extensive surgery on the thyroid gland cited in the literature differ. In large multicenter studies, a wide resection of the thyroid gland proved to be an independent risk factor for permanent HPT [7,17,19]. In the present study, primary total thyroidectomy was found to produce a significant 6.5-fold increase in the risk for PHTP. Some authors, however, did not observe significantly increased permanent HPT rates after total thyroidectomy compared to subtotal thyroidectomy, both performed for benign thyroid disease [21,22,34–38]. In the study by Songun et al., permanent HTP was observed in 5.2% of the patients and there were no significant differences in its occurrence following either subtotal or total resection of the 2 thyroid lobes [39]. Also, Vaiman et al., in their review of 7123 patients, did not find any statistically significant differences in the rates of permanent HPT after total thyroidectomy, subtotal thyroidectomy, and hemithyroidectomy, which were 3.5%, 2.5%, and 0.9%, respectively [40]. On the other hand, according to numerous published reports, goiter recurrence and radical reoperative surgery for thyroid carcinoma are associated with higher rates of parathyroid gland insufficiency compared to primary strumectomy [7,17,19,22,28]. Lefevre et al., in a retrospective analysis of 685 strumectomies, found permanent HPT in 2.5% of the patients [41]. Pappalardo et al. reported a high permanent HPT rate in a study of 141 patients. Out of 9 patients who had undergone reoperative surgery for goiter recurrence, 1 was diagnosed with permanent HPT (11%) [42]. In the present study, the rate was even higher, at 25% (2/8 patients), although it should be emphasized that both groups were very small.

Conclusions

Total thyroidectomy is associated with increased prevalence of permanent hypoparathyroidism when compared to less extensive thyroid resection modes in patients with benign thyroid diseases.

References

1. Chrzan R, Węgiel J, Kulpa T, Tetany as a complication after strumectomy: Pol Przegl Chir, 2010; 82(5); 509-16

2. Dadan J, Nowacka A, A journey into the past – the history of thyroid surgery: Wiad Lek, 2008; 61(1–3); 88-92, pmid: 18717051

3. Nawrot I, Zając S, Grzesiuk W, Effect of surgical technique in subtotal and bilateral thyroidectomy on risk of postoperative parathyroid insufficiency development- our experience: Med Sci Monit, 2000; 6(3); 564-66, pmid: 11208371

4. Trupka A, Sienel W, Autotransplantation of at least one parathyroid gland during thyroidectomy in benign thyroid disease minimizes the risk of permanent hypoparathyroidism: Zentralbl Chir, 2002; 127(5); 439-42, pmid: 12058305

5. Ito Y, Kihara M, Kobayashi K, Permanent hypoparathyroidism after completion total thyroidectomy as a second surgery: how do we avoid it?: Endocr J, 2014; 61(4); 403-8, pmid: 24476946

6. Lang BH, Yih PC, Ng KK, A prospective evaluation of quick intraoperative intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy: World J Surg, 2012; 36(6); 1300-6, pmid: 22399155

7. Thomusch O, Machens A, Sekulla C, The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients: Surgery, 2003; 133(2); 180-85, pmid: 12605179

8. Shoback D, Sellmeyer D, Bikle DD, Metabolic Bone Disease: Greenspan’s Basic and Clinical Endocrinology, 2011; 227-85, International Edition: The McGraw-Hill Companies

9. Franek E, Kokot FHypoparathyroidism: Endokrynologia kliniczna, t. II, 2012; 183-88, Wrocław, Polskie Towarzystwo Endokrynologiczne [in Polish]

10. Jurecka-Lubieniecka B, Paliczka E, Czarniecka AHypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?: Endokrynol Pol, 2006; 5(57); 501-8, pmid: 17133315 [in Polish]

11. Kihara M, Miyauchi A, Kontani K, Recovery of parathyroid function after total thyroidectomy: long-term follow-up study: ANZ J Surg, 2005; 75(7); 532-36, pmid: 15972040

12. Toniato A, Boschin IM, Piotto A, Complications in thyroid surgery for carcinoma: one institution’s surgical experience: World J Surg, 2008; 32(4); 572-75, pmid: 18204947

13. Ríos A, Rodríguez J, Galindo JM, Surgical treatment for multinodular goitres in geriatric patients: Langenbecks Arch Surg, 2005; 390(3); 236-42, pmid: 15654642

14. Raffaelli M, Bellantone R, Princi P, Surgical treatment of thyroid diseases in elderly patients: Am J Surg, 2010; 200(4); 467-72, pmid: 20887839

15. Lang BH, Lo CY, Total thyroidectomy for multinodular goiter in the elderly: Am J Surg, 2005; 190(3); 418-23, pmid: 16105529

16. Seybt MW, Khichi S, Terris DJ, Geriatric thyroidectomy: safety of thyroid surgery in an aging population: Arch Otolaryngol Head Neck Surg, 2009; 135(10); 1041-44, pmid: 19841346

17. Thomusch O, Machens A, Sekulla C, Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany: World J Surg, 2000; 24(11); 1335-41, pmid: 11038203

18. Burge MR, Zeise TM, Johnsen MW, Risks of complication following thyroidectomy: J Gen Intern Med, 1998; 13(1); 24-31, pmid: 9462491

19. Karamanakos SN, Markou KB, Panagopoulos K, Complications and risk factors related to the extent of surgery in thyroidectomy. Results from 2043 procedures: Hormones (Athens), 2010; 9(4); 318-25, pmid: 21112863

20. Rosato L, Avenia N, Bernante P, Complications of thyroid surgery: analysis of a multicentric study on 14934 patients operated on in Italy over 5 years: World J Surg, 2004; 28(3); 271-76, pmid: 14961204

21. Hallgrimsson P, Nordenström E, Bergenfelz A, Almquist M, Hypocalcemia after total thyroidectomy for Graves’ disease and for benign atoxic multinodular goitre: Langenbecks Arch Surg, 2012; 397(7); 1133-37, pmid: 22976368

22. Erbil Y, Barbaros U, Işsever H, Predictive factors for recurrent laryngeal nerve palsy and hypoparathyroidism after thyroid surgery: Clin Otolaryngol, 2007; 32(1); 32-37, pmid: 17298308

23. Witte J, Goretzki PE, Dotzenrath C, Surgery for Graves’ disease: total versus subtotal thyroidectomy-results of a prospective randomized trial: World J Surg, 2000; 24(11); 1303-11, pmid: 11038198

24. Yip J, Lang BH, Lo CY, Changing trend in surgical indication and management for Graves’ disease: Am J Surg, 2012; 203(2); 162-67, pmid: 21683939

25. Domosławski P, Łukieńczuk T, Forkasiewicz Z, Influence of Total Thyroidectomy on Orbital Opthalmopathy and Levels of Antithyroid Antibodies in Patients with Graves’ Disease: Pol Przegl Chir, 2007; 79(3); 303-13

26. McManus C, Luo J, Sippel R, Should patients with symptomatic Hashimoto’s thyroiditis pursue surgery?: J Surg Res, 2011; 170(1); 52-55, pmid: 21435660

27. Wormer BA, McHenry CR, Hashimoto’s thyroiditis: outcome of surgical resection for patients with thyromegaly and compressive symptoms: Am J Surg, 2011; 201(3); 416-19, pmid: 21367390

28. Pattou F, Combemale F, Fabre S, Hypocalcemia following thyroid surgery: incidence and prediction of outcome: World J Surg, 1998; 22(7); 718-24, pmid: 9606288

29. Hallgrimsson P, Nordenström E, Almquist M, Bergenfelz AO, Risk factors for medically treated hypocalcemia after surgery for Graves’ disease: a Swedish multicenter study of 1157 patients: World J Surg, 2012; 36(8); 1933-42, pmid: 22476788

30. Testini M, Gurrado A, Avenia N, Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19662 patients: Ann Surg Oncol, 2011; 18(8); 2251-59, pmid: 21336513

31. Barczyński M, Konturek A, Stopa M, Total thyroidectomy for benign thyroid disease: is it really worthwhile?: Ann Surg, 2011; 254(5); 724-29, pmid: 22005150

32. Barczyński M, Konturek A, Hubalewska-Dydejczyk A, Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter: World J Surg, 2010; 34(6); 1203-13, pmid: 20174803

33. Papier A, Barczyński M, Pragacz K, Staging of thyroid cancer – comparison of cases diagnosed preoperatively versus incidentally after surgery for benign goiter: Przegl Lek, 2013; 70(2); 53-56, pmid: 23879004 [in Polish]

34. Wilhelm SM, McHenry CR, Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves’ disease in the United States: World J Surg, 2010; 34(6); 1261-64, pmid: 20033406

35. Kang AS, Grant CS, Thompson GB, Heerden JA, Current treatment of nodular goiter with hyperthyroidism (Plummer’s disease): surgery versus radioiodine: Surgery, 2002; 132(6); 916-23, pmid: 12490836

36. Ho TW, Shaheen AA, Dixon E, Harvey A, Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study: Am J Surg, 2011; 201(5); 570-74, pmid: 21545901

37. Allimoglu O, Akdag M, Sahin M, Comparison of surgical techniques for treatment of benign toxic multinodular goiter: World J Surg, 2005; 29(7); 921-24, pmid: 15951930

38. Ozbas S, Kocak S, Aydintug S, Comparison of the complications of subtotal, near total and total thyroidectomy in the surgical management of multinodular goiter: Endocr J, 2005; 52(2); 199-205, pmid: 15863948

39. Songun I, Kievit J, Wobbes T, Extent of thyroidectomy in nodular thyroid disease: Eur J Surg, 1999; 165(9); 839-42, pmid: 10533757

40. Vaiman M, Nagibin A, Olevson J, Complication in primary and completed thyroidectomy: Surg Today, 2010; 40(2); 114-18, pmid: 20107949

41. Lefevre JH, Tresallet C, Leenhardt L, Reoperative surgery for thyroid disease: Langenbecks Arch Surg, 2007; 392(6); 685-91, pmid: 17593385

42. Pappalardo G, Guadalaxara A, Frattaroli FM, Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports: Eur J Surg, 1998; 164(7); 501-6, pmid: 9696971

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750